Asclepii's CEO Franco Kraiselburd selected for MIT Innovator Under 35 & 2024 Pioneer of the Year

Asclepii Celebrates CEO Franco Kraiselburd's Recognition as an MIT Innovator Under 35 and 2024 Pioneer of the Year

The 22-year-old was also recognized as Pioneer of the Year

Cleveland, OH — 11/08/2024 — Asclepii is thrilled to announce that CEO Franco Kraiselburd has been honored as an MIT Innovator Under 35 for 2024 and named Pioneer of the Year at the award ceremony held in Lima, Peru, on November 7. Franco, 22, is one of the youngest awardees in the history of the list.

MIT Technology Review highlights Franco's transformative impact in the field of regenerative medicine and affordable wound care. Under Franco's visionary leadership, Asclepii has pioneered advancements in medical devices, focusing on global accessibility and groundbreaking tissue engineering technologies. His commitment to innovation has not only reshaped approaches to healthcare but has also positioned Asclepii at the forefront of the medical technology industry. 

About Asclepii: Headquartered in Cleveland, Ohio, Asclepii is a biomedical engineering company dedicated to developing accessible, innovative medical solutions that improve the quality of life globally. For more information about Asclepii and its mission, visit www.asclepii.com

Contact: William Tavel, william@asclepii.com